Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06940219

Delayed Against Rapid Sequence Induction in Adults With Medical Diseases Undergoing Emergency Endotracheal Intubation.

Led by Leipzig University Medical Center · Updated on 2025-07-04

200

Participants Needed

1

Research Sites

122 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if it is feaseble to conduct a superiority trial comparing two methods for endotracheal intubation in critically ill patients. It will also learn about validity of outcomes regarding endotracheal intubation. The main questions it aims to answer are: * Does performing intubation via Delayed Sequence Induction lower the incidence of severe hemodynamic complications compared to Rapid Sequence Induction? * How are hemodynamic complications in the severely ill to be measured in order to minimize bias? Participants will: * receive emergency endotracheal intubation via Delayed or Rapid Sequence induction * receive a phone call 90 days after endotracheal intubation * outcome parameters outside of follow up phone calls will be routinely collected during the regular ICU-stay, there won't be any additional testing

CONDITIONS

Official Title

Delayed Against Rapid Sequence Induction in Adults With Medical Diseases Undergoing Emergency Endotracheal Intubation.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older in need of emergency endotracheal intubation in the following 60 minutes.
  • The planned operator routinely performs endotracheal intubation in critically ill patients.
Not Eligible

You will not qualify if you...

  • Endotracheal intubation during cardiopulmonary resuscitation or unstable return of spontaneous circulation with high-dose vasopressors.
  • Increased risk for the patient or other reasons that make participation not justifiable, such as active oral bleeding.
  • Known allergy to Ketamine, Esketamine, Midazolam, or Rocuronium.
  • Known contraindication against Ketamine, Esketamine, Midazolam, or Rocuronium.
  • Known or expected difficult airway requiring awake fiberoptic intubation.
  • Women who are pregnant or breastfeeding.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Interdisciplinary Medical ICU, Leipzig Medical University Center

Leipzig, Saxony, Germany, 04317

Actively Recruiting

Loading map...

Research Team

A

Anton J Pelka

CONTACT

S

Sirak Petros, Prof. Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here